A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy

Journal:

Nature Nanotechnology

Published:

2025-06-16

DOI:

10.1038/s41565-025-01952-x

Affiliations:

8

Authors:

13

Go to article

Institutions	Authors	Share
National University of Singapore (NUS), Singapore	6.266667	0.48
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, China	3.833333	0.29
University of Chinese Academy of Sciences (UCAS), China	2.500000	0.19
Clinical Imaging Research Centre (CIRC), Singapore	0.200000	0.02
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	0.200000	0.02

Interested in Oncology and Carcinogenesis?